Evidence map›Paper›PMID 35733784›Full record

ArticleFrontiers in endocrinology2022

Circulating Levels of MiRNAs From 320 Family in Subjects With Lipodystrophy: Disclosing Novel Signatures of the Disease.

Alessia Dattilo, Giovanni Ceccarini, Gaia Scabia, Silvia Magno, Lara Quintino, Caterina Pelosini, Guido Salvetti, Roberto Cusano, Matteo Massidda, Lucia Montanelli and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Alessia DattiloInstitute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Giovanni CeccariniObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Gaia ScabiaObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Silvia MagnoObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Lara QuintinoObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Caterina PelosiniObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Guido SalvettiObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Roberto CusanoCenter for Advanced Studies, Research and Development in Sardinia, Pula (CA), Italy.
Matteo MassiddaCenter for Advanced Studies, Research and Development in Sardinia, Pula (CA), Italy.
Lucia MontanelliDepartment of Clinical and Experimental Medicine, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Donatella GilioObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Gianluca GattiPlastic and Reconstructive Surgery Unit, Hospital of Pisa, Pisa, Italy.
Alessandro GiacominaPlastic and Reconstructive Surgery Unit, Hospital of Pisa, Pisa, Italy.
Mario CostaNational Research Council, Institute of Neuroscience, Pisa, Italy.
Ferruccio SantiniObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
Margherita MaffeiObesity and Lipodystrophy Center, Endocrinology Unit, Pisa University Hospital, Pisa, Italy.
University of Pisa · ITAzienda Ospedaliera Universitaria Pisana · ITCenter for Advanced Studies Research and Development in Sardinia · ITNeuroscience Institute · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipodystrophy (LD) indicates a group of rare disorders, with generalized or partial loss of white adipose tissue (WAT) often associated with metabolic derangements. Heterogeneity/wide spectrum of the disease and lack of biomarkers make diagnosis often difficult. MicroRNAs are important to maintain a correct WAT function and WAT is a source of circulating miRNAs (cmiRs). miRNAs from 320 family were previously detected in the WAT and variably associated to the metabolic syndrome. Our aim was then to investigate if LD can result in altered abundance of cmiRs-320. We collected samples from a cohort of LD subjects of various subtypes and from age matched controls. Use of quantitative PCR determined that cmiRs- 320a-3p, 320b, 320c, 320e are upregulated, while 320d is downregulated in LD. CmiRs-320 power as classifiers was more powerful in the most extreme and defined forms of LD, including the generalized and the Dunnigan subtypes. cmiR-320a-3p showed significant inverse relationships with plasma leptin (P < 0.0001), typically low in LD. The hepatic enzymes gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and the marker of inflammation C-reactive protein (CRP) were inversely related to cmiR 320d (P < 0.05, for CRP and GGT; P < 0.01, for AST and ALT). Gene ontology analysis revealed cell-cell adhesion as a process regulated by 320 miRNAs targets, thus disclosing a novel route to investigate origin of WAT loss/dysfunction. In conclusion, cmiRs-320 constitute novel biomarkers of LD, abundance of miR320a-3p is inversely associated to indicators related to WAT function, while downregulation of cmiR-320d predicts an altered hepatic profile and higher inflammation.

Indexed as

Circulating MicroRNALipodystrophyMicroRNAsBiomarkersC-Reactive ProteinHumansInflammationBiomarkersCirculating MicroRNAC-Reactive ProteinMicroRNAscirculating biomarkergene ontologykobberlinglipodystrophy subtypesmetabolismmiRNA

Identifiers

PMID35733784
PMCPMC9207177
OpenAlexW4281960974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.